Quartzy, a leading vertically integrated procurement platform for life sciences, has announced the successful closing of a new financing round with Avenue Growth Lending and BroadOak Capital Partners. This strategic investment is poised to accelerate the company's next phase of growth and platform enhancement. The capital infusion will bolster Quartzy's mission to streamline laboratory supply chain management for its expanding base of over 3,000 organizations.
Enhancing a Vertically Integrated Platform
The company's platform provides research teams with a unified workflow for managing requests, approvals, purchasing, and inventory. This integrated system offers scientists, lab managers, and procurement staff unprecedented visibility and control over their operations. By centralizing these critical functions, Quartzy helps eliminate common bottlenecks and inefficiencies that can hinder scientific progress.
Quartzy's unique model combines its sophisticated software with a vast supplier network and its own fulfillment infrastructure. According to CEO Jayant Kulkarni, this approach ensures reliability and accountability that fragmented solutions cannot deliver. The platform gives users access to a comprehensive shop with more than 10 million products from over 1,000 industry-leading suppliers.
Strategic Growth and Market Position
The new funding will be directed toward significant investments in Quartzy's software, supplier relationships, and overall customer experience. Kulkarni emphasized that the capital will deepen every layer of the platform to deliver faster fulfillment and better pricing. This focus on continuous improvement is designed to solidify the company's value proposition for its diverse user base.
Investor confidence in Quartzy's model is strong, with Bill Snider of BroadOak Capital Partners noting the company's powerful market position. He highlighted the significant value Quartzy adds to thousands of research labs and their suppliers. This partnership reflects a long-standing interest in Quartzy's progress and its substantial impact on the life sciences sector.
Investor Confidence and Future Outlook
The financing comes from firms with deep expertise in the sector, reinforcing the strategic nature of the deal. Avenue Growth Lending specializes in creative financing solutions for high-growth technology and life science companies. BroadOak Capital Partners is a life science-focused investment firm with a long history of backing innovative companies in the field.
The transaction was facilitated by a team of experienced advisors, ensuring a smooth and successful process for all parties involved. Spinta Capital served as the placement agent to Quartzy in connection with the transaction. Legal counsel was provided by Cooley LLP for Quartzy, while DLA Piper LLP served as legal counsel to the lenders.
This new financing marks a pivotal moment for Quartzy, empowering it to further enhance its comprehensive procurement platform for the scientific community. The investment from Avenue Growth Lending and BroadOak Capital Partners validates the company's integrated strategy and market leadership. Consequently, Quartzy is well-positioned to accelerate its growth and continue delivering exceptional value to its customers.